D6068
N-[4-[(6,7-Dimethoxy-4-quinazolinyl)amino]phenyl]benzamide hydrochloride
≥98% (HPLC), solid
동의어(들):
4-(4′-Benzamidoanilino)-6,7-dimethoxyquinazoline hydrochloride, Aurora Kinase Inhibitor II
로그인조직 및 계약 가격 보기
모든 사진(1)
About This Item
실험식(Hill 표기법):
C23H20N4O3 · HCl
CAS Number:
Molecular Weight:
436.89
MDL number:
UNSPSC 코드:
12352200
PubChem Substance ID:
NACRES:
NA.77
추천 제품
분석
≥98% (HPLC)
양식
solid
색상
yellow
solubility
H2O: <2 mg/mL
DMSO: ~2.4 mg/mL (with warming up to 60°C for 1 minute)
주관자
AstraZeneca
저장 온도
2-8°C
SMILES string
Cl.COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC
InChI
1S/C23H20N4O3.ClH/c1-29-20-12-18-19(13-21(20)30-2)24-14-25-22(18)26-16-8-10-17(11-9-16)27-23(28)15-6-4-3-5-7-15;/h3-14H,1-2H3,(H,27,28)(H,24,25,26);1H
InChI key
OQCLKJREASBKNO-UHFFFAOYSA-N
생화학적/생리학적 작용
Aurora Kinase Inhibitor
특징 및 장점
This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Nicola M Heron et al.
Bioorganic & medicinal chemistry letters, 16(5), 1320-1323 (2005-12-13)
A novel series of 5-aminopyrimidinyl quinazolines has been developed from anilino-quinazoline 1, which was identified in a high throughput screen for Aurora A. Introduction of the pyrimidine ring and optimisation of the substituents both on this ring and at the
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.